Brief: Aroa Biosurgery Receives U.S. FDA 510K Clearance For Its Enivo Pump And Catheter
12/04/2023 01:52
April 12 (Reuters) - Aroa Biosurgery Ltd ARX.AX :
* RECEIVED U.S. FDA 510K CLEARANCE FOR ITS ENIVO PUMP AND
CATHETER
Source text for Eikon: ID:nASX2bsRr7
Further company coverage: ARX.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Aroa Biosurgery
See all newsAustralia-listed Aroa Biosurgery climbs as annual earnings beat guidance
Brief: Aroa Biosurgery Posts Adjusted EBITDA Of NZ$12.6 Million
Aroa Biosurgery climbs as prelim annual results beat outlook
Brief: Aroa Biosurgery Posts FY26 Prelim Total Revenue Of NZ$104 Million
Brief: Aroa Biosurgery Says Expects FY26 Revenue At Upper End Of NZ$92-100 Million